In this video, Lumos Diagnostics CEO Doug Ward discusses the Company's recent quarterly activity statement and cash flow report, and notable achievements and milestones from Q3 FY24.
Company News
Quarterly | Interview with LDX CEO, Doug Ward
30 Apr 2024
Keep reading
More news & media.
A few more pieces along the same thread. See the full index for everything.
COMPANY NEWS
1 min read
MST Access research report
MST Access has published a research report on Lumos Diagnostics Limited.
LD
Lumos Diagnostics Communications
Written with AI assistance
COMPANY NEWS
2 min read
FebriDx® Commercial Traction Continues to Advance
Lumos Diagnostics has announced further progress in the U.S. commercialisation of FebriDx® across its priority top-100 urgent care target list.
LD
Lumos Diagnostics Communications
Written with AI assistance
COMPANY NEWS
1 min read
REPLAY | FebriDx US Launch Update
Lumos CEO Doug Ward, Lumos Chief Commercial Officer Paul Kase, Lumos Director of U.S. Sales
LD
Lumos Diagnostics Communications
Written with AI assistance